Online inquiry

IVTScrip™ mRNA-Human ABHD2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK9368MR)

This product GTTS-WK9368MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ABHD2 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_007011.8
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 11057
UniProt ID P08910
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABHD2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK9368MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16069MR IVTScrip™ mRNA-Human ANAPC15, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANAPC15
GTTS-WK12366MR IVTScrip™ mRNA-Human ABHD17A, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABHD17A
GTTS-WK25088MR IVTScrip™ mRNA-Human ARV1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARV1
GTTS-WK5825MR IVTScrip™ mRNA-Human HMOX1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA HMOX1
GTTS-WK28684MR IVTScrip™ mRNA-Human ARSE, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARSE
GTTS-WK20861MR IVTScrip™ mRNA-Human AMT, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA AMT
GTTS-WK18396MR IVTScrip™ mRNA-Human ALDH1A3, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALDH1A3
GTTS-WK8919MR IVTScrip™ mRNA-Human ADCY1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADCY1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW